TY - JOUR
T1 - Protease-activated receptor-2 regulates bicarbonate secretion by pancreatic duct cells in vitro
AU - Alvarez, Carlos
AU - Regan, Joseph P.
AU - Merianos, Demetri
AU - Bass, Barbara L.
N1 - Funding Information:
Supported by the Merit Review Entry Program of the Medical Research Service, Department of Veteran Affairs.
PY - 2004/9
Y1 - 2004/9
N2 - Background Pancreatic duct cells (PDCs) are responsible for bicarbonate production by the pancreas. The trypsin-sensitive protease-activated receptor (PAR-2), also known as the trypsin receptor, is highly expressed in the pancreatic duct system and has been shown to regulate PDC ion transport. The possible role of this receptor on bicarbonate secretion, the central function of duct cells, is unknown. We hypothesize that PAR-2 may regulate pancreatic bicarbonate secretion during times of inappropriate pancreatic enzyme activation. Methods To study this hypothesis in vitro, explants of the bovine main pancreatic duct were isolated and maintained in primary culture. They were then mounted in Ussing chambers, and bicarbonate secretion was determined with an autoburette titration. The response to luminal or serosal trypsin (10 μmol/L) and the synthetic trypsin receptor activating peptide (TRAP) (30 μmol/L) on spontaneous and secretin-stimulated bicarbonate secretion (10 nmol/L) was examined. Results Serosal trypsin had no effect. Both luminal trypsin and TRAP significantly reduced the spontaneous bicarbonate secretion observed at luminal pH 7.4 (2.8 ± 0.2 - 0.4 ± 0.1 μmol/hr/cm2 and 4.0 ± 1.2 - 1.6 ± 0.4 μmol/hr/cm2, respectively) in a reversible manner. Baseline bicarbonate secretion at luminal pH 8.0 was reduced by trypsin and TRAP, but the increase in response to secretin stimulation observed with controls was unaffected. Conclusions PAR-2 activation may be the mechanism by which pancreatic juice secretion is inhibited during pancreatitis. We suggest that pharmacologic activation of PAR-2 receptors could suppress pancreatic exocrine secretion and thus serve as a potential agent in the treatment and prevention of pancreatic fistulas.
AB - Background Pancreatic duct cells (PDCs) are responsible for bicarbonate production by the pancreas. The trypsin-sensitive protease-activated receptor (PAR-2), also known as the trypsin receptor, is highly expressed in the pancreatic duct system and has been shown to regulate PDC ion transport. The possible role of this receptor on bicarbonate secretion, the central function of duct cells, is unknown. We hypothesize that PAR-2 may regulate pancreatic bicarbonate secretion during times of inappropriate pancreatic enzyme activation. Methods To study this hypothesis in vitro, explants of the bovine main pancreatic duct were isolated and maintained in primary culture. They were then mounted in Ussing chambers, and bicarbonate secretion was determined with an autoburette titration. The response to luminal or serosal trypsin (10 μmol/L) and the synthetic trypsin receptor activating peptide (TRAP) (30 μmol/L) on spontaneous and secretin-stimulated bicarbonate secretion (10 nmol/L) was examined. Results Serosal trypsin had no effect. Both luminal trypsin and TRAP significantly reduced the spontaneous bicarbonate secretion observed at luminal pH 7.4 (2.8 ± 0.2 - 0.4 ± 0.1 μmol/hr/cm2 and 4.0 ± 1.2 - 1.6 ± 0.4 μmol/hr/cm2, respectively) in a reversible manner. Baseline bicarbonate secretion at luminal pH 8.0 was reduced by trypsin and TRAP, but the increase in response to secretin stimulation observed with controls was unaffected. Conclusions PAR-2 activation may be the mechanism by which pancreatic juice secretion is inhibited during pancreatitis. We suggest that pharmacologic activation of PAR-2 receptors could suppress pancreatic exocrine secretion and thus serve as a potential agent in the treatment and prevention of pancreatic fistulas.
UR - http://www.scopus.com/inward/record.url?scp=4444376075&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4444376075&partnerID=8YFLogxK
U2 - 10.1016/j.surg.2004.01.018
DO - 10.1016/j.surg.2004.01.018
M3 - Article
C2 - 15349117
AN - SCOPUS:4444376075
SN - 0039-6060
VL - 136
SP - 669
EP - 676
JO - Surgery
JF - Surgery
IS - 3
ER -